Secher A, Jelsing J, Baquero AF, Hecksher-Sorensen J, Cowley MA, Dalboge LS, Hansen G, Grove KL, Pyke C, Raun K, et al
Theres a region in your brain called the VTAthe ventral tegmental area
GLP-1 and SGLT-2 have the highest level of clinical evidence for use in this population, per the American Diabetes Association (ADA) guidelines.[3] Both GLP-1 and SGTL-2 products, such as Jardiance, have the ability to improve blood glucose control (hemoglobin A1c reduction), potentiate weight loss and provide a cardiovascular protective effect
Most people lose about 10-15% of their starting weight within a year of taking GLP-1 medications
Fayemi AO, Shifting Focus From Glycemic Statsus to Insulin Homeostasis
Choose the protocol that fits your biology